Patents
Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
03/2008
03/26/2008CN100376564C Substituted heterocyclic benzoeycloalkenes and the use thereof as substances having analgesic effect
03/25/2008US7348032 Using plant extracts as antiproliferative agents
03/20/2008WO2007113327A3 Fungicide n-cyclopropyl-sulfonylamide derivatives
03/20/2008US20080070916 Treating disorders such as proliferative diseases, and cancer; compounds can act as probes of biological function; libraries; for example, 2-ethoxy-3-(2-hydroxyethoxyethoxyethyl)-4-(1-acetylindol-3-yl)-6-(morpholinocarbonyl)-2H-3,4-dihydropyran
03/19/2008EP1899315A1 Benzofuranone derivatives as nonsteroidal progesterone receptor modulators
03/19/2008EP1899296A1 Histamine-3 receptor antagonists
03/19/2008EP1562933B1 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders
03/19/2008EP1532132B1 Novel benzodioxoles
03/18/2008US7345140 Phenol-reacted non-ester alicyclic diepoxides
03/18/2008US7345094 Synergistic; side effect reduction; melanomas; toxicity; 2,5-Dimethoxythiobenzoic Acid N-methylhydrazine; anticancer
03/18/2008US7344761 Containing 3 directly connected rings: a fluorophenyl ring, a tetrahydropyran ring and either another tetrahydropyran ring or a 1,3-dioxane ring; electrooptical displays;
03/13/2008WO2007146838A3 Substituted phenyl acetic acids as dp-2 antagonists
03/13/2008US20080064700 Aryl triazines as LPAAT-beta inhibitors and uses thereof
03/12/2008EP1896456A2 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
03/12/2008EP1896411A2 Process for preparing renin inhibitors
03/12/2008EP1539693B1 Cannabinoid receptor agonists
03/12/2008CN101142210A Fumagillol derivatives or method for preparation of fumagillol derivatives, and pharmaceutical compositions comprising the same
03/11/2008US7341993 Cross-linked glycopeptide—cephalosporin antibiotics
03/11/2008CA2223535C 2,4-pentadienoic acid derivatives having retinoid-like biological activity
03/06/2008WO2008028118A1 1h-indole-2-carboxylic acid derivatives useful as ppar modulators
03/06/2008WO2008025534A1 Preparation and purification of mupirocin calcium
03/06/2008US20080058519 Quinazoline ditosylate salt compounds
03/06/2008US20080058334 Dermatological or oncological disorders; N-(4-fluorophenyl)-N'-[4-[1-(1H-imidazol-1-yl)-2-methylpropyl]phenyl]urea for example
03/06/2008US20080058320 Organic Compounds
03/06/2008CA2662274A1 Chemical compounds
03/06/2008CA2649758A1 Preparation and purification of mupirocin calcium
03/05/2008EP1893603A1 Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists
03/05/2008EP1893573A1 Inhibitors of hcv replication
03/05/2008EP1633748B1 Quinoline derivatives as phosphodiesterase inhibitors
03/05/2008EP1383756B1 Coumarin derivatives to be used as anticoagulants
03/05/2008CN101137650A 2-[(isoquinolin-3-carbonyl)amino]-propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis
03/05/2008CN101137414A 多环双酰胺mmp抑制剂 Polycyclic bisamides mmp inhibitors
03/05/2008CN100372840C Intermediate for the preparation of epimino
02/2008
02/28/2008WO2008022725A1 Biphenyl substituted spirotetronic acids and their use for the treatment of retroviral disorders
02/28/2008WO2008006113A3 Novel belactosin derivatives as therapeutic agents/biological probes and their synthesis
02/28/2008US20080051587 Method for Extracting Cocoa Procyanidins
02/28/2008US20080051577 Cross-linked glycopeptide-cephalosporin antibiotics
02/28/2008CA2660084A1 Biphenyl substituted spirotetronic acids and their use for the treatment of retroviral diseases
02/27/2008EP1891951A1 Viral polymerase inhibitors
02/27/2008EP1891950A1 Viral polymerase inhibitors
02/27/2008EP1891059A1 Pyran/dioxan derivatives and use thereof in liquid crystal media
02/27/2008EP1453827B1 Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof
02/27/2008EP1268470B1 Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof
02/27/2008CN101130514A Intermediate for the preparation of epimino
02/27/2008CN100370980C C-2' methylated derivatives of paclitaxel for use as antitumour agents
02/26/2008US7335677 Inhibitors of dipeptidyl peptidase IV
02/26/2008US7335660 Using a 2-benzopyran-6-carboxamide compound
02/21/2008WO2008022104A1 Costunolide derivatives
02/21/2008WO2008020607A1 Phthalide derivative and salt thereof
02/21/2008WO2008020490A1 Artocarpine derivative or artocarpine-like compound, and hair growth/restoration composition, skin-whitening cosmetic composition, pharmaceutical as anti-cancer, antiphlogistic/analgesic, antipyretic or antiallergic agent and pharmaceutical for treatment of pigmented skin lesion each comprising the same
02/21/2008WO2008019985A1 Method of purifying theaflavins
02/21/2008WO2007149448A3 Pyrazinones as cellular proliferation inhibitors
02/21/2008WO2007121389A3 4,4-disubstituted piperidine derivatives as nk-i and serotonin transporter inhibitors
02/21/2008WO2007062158B1 Adducts of levulinic derivatives with epoxidized fatty acid esters and uses thereof
02/21/2008US20080045721 Thiazole-oxime chemical intermediates to cephalosporin-linked vancomycin derivatives which have use against antibiotic-resistant bacteria including methicillin-resistant Staphylococci aureus (MRSA)
02/21/2008US20080045576 Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives
02/20/2008EP1889843A1 Bisheterocycle tandem compounds useful as antiviral agents, the uses thereof and the compositions comprising such compounds
02/20/2008EP1889839A1 Bicyclic compound, production and use as HIV inhibitors
02/20/2008EP1888707A1 New materials for organic electroluminescence devices
02/20/2008EP1888566A1 2-[(isoquinolin-3-carbonyl)amino]-propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis
02/20/2008EP1888565A2 2, 6-di (hetero) aryl -4-amido-pyrimidines as adenosine receptor antagonists
02/20/2008EP1888517A1 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor
02/20/2008EP1888058A2 Inhibitors of soluble adenylate cyclase
02/20/2008CN100369911C Valienamine A-4,7,4',7'-diacetal or ketone compound, and its preparation and use
02/19/2008US7332523 TNP-470 polymer conjugates and use thereof
02/19/2008US7332511 Vanilloid receptor ligands and their use in treatments
02/19/2008US7332260 Naphthopyrans annelated in C5-C6, their preparation and compositions and (CO)polymer matrices containing them
02/14/2008WO2008019135A1 Antiproliferative activity of the leiodermatolide class of macrolides
02/14/2008WO2007110704A3 Macrolide compositions as therapeutic agent
02/14/2008US20080039611 Cross-linked glycopeptide-cephalosporin antibiotics
02/14/2008US20080039502 e.g. N-[4-(4'-Methoxy-biphenyl-4-yloxymethyl)-5-methyl-furan-2-carbonyl]-benzenesulfonamide; prostaglandin E4 receptor antagonist; analgesic, antiinflammatory agent; migraines and headache
02/14/2008US20080039374 Cross-lined glycopeptide-cephalosporin antibiotics
02/14/2008DE102006037724A1 Verwendung von Ascorbinsäurederivaten zur Funktionalisierung von Matrices Use of ascorbic acid for the functionalization of matrices
02/13/2008EP1335908B1 Peroxisome proliferator activated receptor alpha agonists
02/13/2008CN101124221A Purification of mupirocin
02/12/2008US7329766 Process for stereoselectively reducing 4-aryl-4-oxobutanoic acid derivatives
02/07/2008WO2008016187A1 Pladienolide target molecule, compound capable of binding to the target molecule, and screening method for the compound
02/07/2008US20080033035 Animal extract from a deep-water sponge of the genus Leiodermatium collected in the US and Bahamas; polyene macrolide antibiotics; multidrug resistant cancers; potentinhibition of mitosis by causing a G2/M block; anticarcinogenic, -tumor, -proliverative and -inflammatory agents; autoimmune diseases
02/07/2008US20080032977 Alkyne-substituted pyridone compounds and methods of use
01/2008
01/31/2008WO2008012372A1 Process for the preparation of candesartan cilexetil form i
01/31/2008WO2008012371A1 Process for the preparation of amorphous and crystalline forms of candesartan cilexetil using column chromatography
01/31/2008US20080027133 Use of chromen-4-one derivatives
01/30/2008EP1881975A1 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
01/30/2008CN101115742A Heterocycle derivatives as histone deacetylase (hdac) inhibitors
01/30/2008CN101115734A Spiro derivatives as lipoxygenase inhibitors
01/30/2008CN100364967C Method for the production of bisepoxides and dithiols
01/29/2008US7323494 Liver X receptor(LXR) modulating agents, agonists; useful in increasing ABCA1, ABCG1, and apolipoprotein E expression, increasing cholesterol efflux from peripheral cells, treating cardiovascular disease, inflammation; 2-[2-{[4-methoxy-benzyl](2,2-diphenylethyl)amino}ethyl]-5-benzofuran acetic acid
01/29/2008US7323470 2-Heterocyclyl- indole, pyrrolopyridine, pyrrolopyrimidine, or pyrrolopirazine substituted with an N-(amino)sulfonyl(thio)carboxamide: 3-Cyclohexyl-2-furan-3-yl-7-methyl-1H-indole-6-(N-methylsulfonyl)carboxamide; treating a hepatitis virus infection
01/24/2008WO2008011117A2 Antiviral protease inhibitors
01/24/2008WO2008009741A1 Novel chromene and thiochromene carboxamide derivatives, methods for preparing same and therapeutic applications of same
01/24/2008WO2008009406A1 Novel pyridazine derivatives
01/24/2008WO2008009405A2 Novel pyridazine derivatives
01/24/2008WO2007136668A3 N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists
01/24/2008WO2007123953A3 Phosphodiesterase 4 inhibitors
01/24/2008WO2007096261A3 Process for the preparation of dioxane derivatives
01/24/2008US20080021025 Inhibitors of cathepsin s
01/24/2008US20080020148 Chromane Derivatives Method for Production and the Use Thereof
01/24/2008CA2659524A1 Novel chromene and thiochromene carboxamide derivatives, methods for preparing same and therapeutic applications of same
01/24/2008CA2658764A1 Benzothiophene inhibitors of rho kinase
01/24/2008CA2658254A1 Novel pyridazine derivatives
1 ... 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 ... 120